Antibiotic single-dose prophylaxis of shunt infections

J Blum1, M Schwarz, D Voth

  • 1Department of Neurosurgery, Mainz University Hospital, West Germany.

Neurosurgical Review
|January 1, 1989
PubMed

Insights

Prophylactic cefazedone significantly reduced shunt infections in pediatric hydrocephalus patients, decreasing rates from 14% to 6%. This antibiotic effectively lowers post-operative infection risk following cerebrospinal fluid (CSF) shunt procedures.

Area of Science:

  • Neurosurgery
  • Pediatric Infectious Diseases
  • Pharmacology

Background:

  • Shunt infections are serious complications following cerebrospinal fluid (CSF) drainage for hydrocephalus.
  • These infections can occur after initial shunt implantation or revision surgery.
  • The frequency of these infections necessitates effective preventative strategies.

Purpose of the Study:

  • To evaluate the efficacy of prophylactic cefazedone in reducing post-operative infection rates.
  • To assess the impact of a single antibiotic dose on shunt infection incidence in pediatric hydrocephalus.
  • To compare infection rates in children receiving prophylactic antibiotics versus an untreated control group.

Main Methods:

  • A prospective study involving 50 pediatric patients (up to 14 years) with hydrocephalus.
  • One group received a single prophylactic dose of cefazedone; a similar group served as the untreated control.
  • Infection diagnosis relied primarily on microbiological and clinical assessments, with classical parameters playing a secondary role.

Main Results:

  • The infection rate in the cefazedone-treated group was 6%.
  • The untreated control group experienced a higher infection rate of 14%.
  • Prophylactic cefazedone demonstrated a significant reduction in post-operative shunt infections.

Conclusions:

  • A single prophylactic dose of cefazedone is effective in reducing shunt infections in pediatric hydrocephalus patients.
  • Antibiotic prophylaxis with cefazedone is a viable strategy to decrease post-operative infection rates.
  • This approach offers a potential improvement in outcomes for children undergoing CSF shunt procedures.

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...